Literature DB >> 6199142

Murine anti-lymphocyte monoclonal antibodies fail to act as opsonins for allogeneic human peripheral blood polymorphonuclear phagocytes.

D M Roberton, G M Georgiou, W M Ellis, C S Hosking.   

Abstract

Seven murine monoclonal antibodies (MoAbs) to antigenic determinants present on human lymphocytes did not promote phagocytosis of allogeneic human lymphocytes by human peripheral blood polymorphonuclear leucocytes (PML). Similarly there was no significant metabolic activation of PML as determined by incorporation of radiolabelled iodide. The opsonic activity of MoAbs was not enhanced by addition of human or rabbit complement nor by the use of sheep anti-mouse IgG, rabbit anti-mouse immunoglobulin or goat anti-mouse immunoglobulin as second antibody. Whole serum from mice immunized with human lymphocytes did not act as an opsonin when tested with human PML. Hyperimmune mouse antiserum to Bordetella pertussis antigen acted only weakly as an opsonin. Human PML may not have an in vivo role in the removal of allogeneic lymphocytes treated with murine anti-lymphocyte MoAbs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199142      PMCID: PMC1535802     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Complexity of the human T lymphocyte-specific cell surface antigen T3.

Authors:  J Borst; M A Prendiville; C Terhorst
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

2.  A randomized study of the prevention of acute graft-versus-host disease.

Authors:  N K Ramsay; J H Kersey; L L Robison; P B McGlave; W G Woods; W Krivit; T H Kim; A I Goldman; M E Nesbit
Journal:  N Engl J Med       Date:  1982-02-18       Impact factor: 91.245

3.  Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.

Authors:  H Rodt; H J Kolb; B Netzel; R J Haas; K Wilms; C B Götze; H Link; S Thierfelder
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Receptors for human gamma G globulin on human neutrophils.

Authors:  R P Messner; J Jelinek
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

5.  Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.

Authors:  A B Cosimi; R C Burton; R B Colvin; G Goldstein; F L Delmonico; M P LaQuaglia; N Tolkoff-Rubin; R H Rubin; J T Herrin; P S Russell
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

6.  Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

Authors:  H G Prentice; H A Blacklock; G Janossy; K F Bradstock; D Skeggs; G Goldstein; A V Hoffbrand
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

7.  Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

Authors:  A H Filipovich; P B McGlave; N K Ramsay; G Goldstein; P I Warkentin; J H Kesey
Journal:  Lancet       Date:  1982-06-05       Impact factor: 79.321

8.  OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.

Authors:  H G Prentice
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

9.  Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

Authors:  E L Reinherz; R Geha; J M Rappeport; M Wilson; A C Penta; R E Hussey; K A Fitzgerald; J F Daley; H Levine; F S Rosen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  T cell depletion of human bone marrow using monoclonal antibody and complement-mediated lysis.

Authors:  T G Sharp; D H Sachs; A S Fauci; G L Messerschmidt; S A Rosenberg
Journal:  Transplantation       Date:  1983-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.